Corrected: BRIEF-Hologic Q2 Adjusted EBITDA USD 325.8 Million Vs. IBES Estimate USD 324.7 Million
May 01 (Reuters) - Hologic Q2 revenue USD 1,005.3 million vs. IBES estimate USD 1,000 million. Q2 gross margin 37.5% Q2 net income USD -17.4 million Q2 adjusted gross margin 61.1% Q2 adjusted operating margin 30% outlook FY adjusted EPS USD 4.15-4.25 outlook FY EPS USD 2.47-2.57
Recent news on Hologic
See all newsBrief: Blackstone And Tpg Complete Acquisition Of Hologic
Casey's General Stores edges higher ahead of replacing Hologic in S&P 500
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: S&P Dow Jones Indices Says Casey's General Stores Inc. Will Replace Hologic Inc. In The S&P 500 Effective Prior To The Market Open On April 9